152 results on '"Marlink, Richard G."'
Search Results
2. Hybrid data capture for monitoring patients on highly active antiretroviral therapy (HAART) in urban Botswana
3. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia
4. Pregnancy rates and birth outcomes among women of efavirenz-containing highly active antiretroviral therapy in Botswana
5. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana
6. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: Feasibility and early outcomes: Feasibility and early outcomes
7. Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned
8. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting
9. Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana
10. Five-year outcomes of initial patients treated in Botswanaʼs National Antiretroviral Treatment Program
11. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors
12. Slower heterosexual spread of HIV-2 than HIV-1
13. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts
14. Cost-effective diagnosis of HIV-1 and HIV-2 by recombinant-expressed env peptide (566/996) dot-blot analysis
15. Risk factors for HIV-1 and HIV-2 infection in pregnant women in Dakar, Senegal
16. Non-Nucleoside Reverse Transcriptase Inhibitor Outcomes Among cART-Treated Adults in Botswana
17. Hybrid data capture for monitoring patients on highly active antiretroviral therapy (HAART) in urban Botswana
18. Access to HIV and AIDS Care
19. Persistently Elevated Serum Interleukin-6 Predicts Mortality Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial
20. Effect Modification by Sex and Baseline CD4+Cell Count Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial
21. Risk Factors for Symptomatic Hyperlactatemia and Lactic Acidosis Among Combination Antiretroviral Therapy-Treated Adults in Botswana: Results from a Clinical Trial
22. Prevalence of Transmitted HIV Drug Resistance in Botswana: Lessons Learned from the HIVDR-Threshold Survey Conducted Among Women Presenting for Routine Antenatal Care as Part of the 2007 National Sentinel Survey
23. Transfusion-Acquired Human Immunodeficiency Virus Infection Among Immunocompromised Persons
24. Psychosocial Factors Affecting Medication Adherence Among HIV-1 Infected Adults Receiving Combination Antiretroviral Therapy (cART) in Botswana
25. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges
26. Response to Zidovudine/Didanosine-Containing Combination Antiretroviral Therapy Among HIV-1 Subtype C-Infected Adults in Botswana: Two-Year Outcomes from a Randomized Clinical Trial
27. Higher-Than-Expected Rates of Lactic Acidosis Among Highly Active Antiretroviral Therapy-Treated Women in Botswana
28. Drug Resistance Profiles of Recombinant Reverse Transcriptases from Human Immunodeficiency Virus Type 1 Subtypes A/E, B, and C
29. Antibodies to the HIV Type 2 Core Protein p26 and Vpx: Association with Disease Progression
30. Distinct Quasi-Species in the Blood and the Brain of an HIV-2-Infected Individual
31. Intrapatient Variability of the Human Immunodeficiency Virus Type 2 Envelope V3 Loop
32. Persistently Elevated Serum lnterleukin-6 Predicts Mortality Among Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial.
33. Effect Modification by Sex and Baseline CD4+ Cell Count Annong Adults Receiving Combination Antiretroviral Therapy in Botswana: Results from a Clinical Trial.
34. Hepatic arterial embolization for metastatic hormone-secreting tumors technique, effectiveness, and complications
35. Evaluation of the False Recent Classification Rates of Multiassay Algorithms in Estimating HIV Type 1 Subtype C Incidence
36. Effect of Micronutrient Supplementation on Disease Progression in Asymptomatic, Antiretroviral-Naive, HIV-Infected Adults in Botswana
37. Immunohaematological reference values for HIV-negative healthy adults in Botswana
38. Association between Virus-Specific T-Cell Responses and Plasma Viral Load in Human Immunodeficiency Virus Type 1 Subtype C Infection
39. Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C
40. Africa and the biology of human immunodeficiency virus
41. Clinical, Hematologic, and Immunologic Cross-Sectional Evaluation of Individuals Exposed to Human Immunodeficiency Virus Type-2 (HIV-2)
42. Monitoring HIV-1 Subtype Distribution
43. Simian Immunodeficiency Viruses and the Origin of HIVs
44. Molecular Diagnosis of HIV Infection
45. Effect of Genetic Variation on HIV Transmission and Progression to AIDS
46. Biology of Human Immunodeficiency Virus Type 2 (HIV-2)
47. Gender and HIV/AIDS
48. Serodiagnosis of HIV Infection
49. HIV-1 Vaccine Testing, Trial Design, and Ethics
50. Prevention of Breast Milk Transmission of HIV : Balancing the Benefits and the Risks
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.